Both in Pharmaceuticals
Neurogene vs Ovid Therapeutics
Over the past year NGNE returned −19.9% and OVID returned +45.3%; their daily moves had a correlation of 0.23.
NGNE −19.9% OVID +45.3%Growth of $1, one year, split-adjusted
| Metric | NGNE | OVID |
|---|---|---|
| Price | $23.25 | $2.15 |
| Market cap | $465.3M | $419.9M |
| Today | −2.92% | −4.87% |
| 1 month | −28.3% | −20.4% |
| 6 months | −16.5% | −26.1% |
| Year to date | +12.9% | +31.9% |
| 1 year | −32.4% | +30.3% |
| Revenue growth (YoY) | — | −88.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −2047.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 265.2× |
| Net cash | $225.4M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 63.1% | 53.1% |
| Short % of float | 38.6% | 12.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).